An experimental treatment appears to delay Alzheimer’s symptoms in some people genetically destined to get the disease in ...

Just like Taylor Swift during her Eras Tour, it seems like weight loss supplements are everywhere right now—and that includes insulin resistance supps. Supplement companies market insulin resistance ...

NIH has launched a human trial for LASSARAB, a dual-purpose vaccine targeting Lassa fever and rabies. Early animal studies ...

Proposition 103 may have been well-intentioned, but good intentions often lead to unintended consequences. Insurance ...

Massachusetts General Hospital received $655 million in funding from the National Institutes of Health in fiscal 2024 — a slight decrease from the $675 million it secured in 2023, yet it remained the ...

HHS Secretary RFK Jr., with help from DOGE, is planning a restructuring with sweeping cuts expected at multiple agencies.

Sam Srisatta, a 20-year-old Florida college student, spent a month living inside a government hospital here last fall, ...

Proposed cuts to National Institutes of Health funding threaten a critical pipeline of innovation and discovery necessary to fuel advancements in patient care, according to researchers and provider ...

The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.

The bulk of the terminated grants have to do with vaccine hesitancy, HIV, Black or Latino communities and/or sex, gender and ...

Sunflower seeds are one of the healthiest seeds you can eat and one of the best sources of vitamin E, says McWhorter. A ...

To systematically end active awards is a departure for NIH, which has terminated grants to Duke, UNC and RTI International.